How This Checker Works
This tool mirrors the eligibility logic published on Medicare.gov for the GLP-1 Bridge program. It checks four things, in order: whether you have qualifying Medicare drug coverage, whether you're 18 or older, whether you're excluded because you're already covered elsewhere or have a disqualifying diagnosis, and finally whether your BMI plus any relevant health conditions clear the program's threshold.
Why some people with a lower BMI still qualify: The Bridge uses a sliding scale. A BMI of 35+ qualifies on its own. A BMI of 30–34.9 needs one added condition (like uncontrolled hypertension or prediabetes). A BMI of 27–29.9 needs a more specific condition — prediabetes, a prior heart attack or stroke, or symptomatic peripheral artery disease.
Why some people are excluded even with a high BMI: If you have type 2 diabetes, moderate-to-severe obstructive sleep apnea, or MASH (fatty liver disease), your regular Part D plan may already be required to cover a GLP-1 drug for that diagnosis — so CMS routes you there instead of through the Bridge.
Program Timeline
- July 1, 2026The Medicare GLP-1 Bridge launches nationwide; prior authorization requests begin processing.
- Through Dec 31, 2027The Bridge runs as a short-term demonstration outside normal Part D coverage and payment flow.
- Oct 15 – Dec 7, 2026Medicare Open Enrollment — decisions plans make here affect what happens after the Bridge ends.
- Dec 31, 2027The Bridge is scheduled to end; a longer-term coverage framework (the BALANCE Model) has had its 2027 Part D rollout delayed indefinitely.
Glossary
- Medicare GLP-1 Bridge
- A temporary CMS demonstration (July 2026–Dec 2027) giving eligible Part D beneficiaries access to certain GLP-1 drugs for weight loss outside normal Part D coverage.
- BMI (Body Mass Index)
- A weight-to-height ratio used as the primary clinical threshold for Bridge eligibility.
- HFpEF
- Heart failure with preserved ejection fraction, also called diastolic heart failure — one of the qualifying conditions at BMI 30–34.9.
- MASH
- Metabolic dysfunction-associated steatohepatitis, a form of fatty liver disease that excludes you from the Bridge because Part D may already cover a GLP-1 for it.
- Prior authorization
- The approval step your provider must complete with the Bridge's central processor before your pharmacy can fill a covered prescription.
What To Do With Your Result
Bring your result to your provider
Your doctor needs to certify that you're using the GLP-1 as part of a lifestyle program focused on diet and exercise, and submit the prescription plus any requested prior authorization.
Confirm your Part D plan type
If you're unsure whether your plan qualifies, call 1-800-MEDICARE (1-800-633-4227; TTY 1-877-486-2048) before your appointment.
Watch your mail
If approved, you'll get a letter confirming your GLP-1 is covered under the Bridge. Your prior authorization stays valid through December 31, 2027, unless you switch GLP-1s.
Not eligible? Compare other options
Check manufacturer savings programs, your state's pharmaceutical assistance programs, mail-order pricing, and cash-price comparison tools like TrumpRx.gov.